To the Editor.— Elicitation or exacerbation of psoriasis has occurred following administration of the psychopharmacologic agents,1β-blockers,2nonsteroidal anti-inflammatory agents,3antimalarials,4isotretinoin,5and chlorthalidone.6Abel and coworkers7have extensively analyzed and discussed the entire subject of drug-induced psoriasis in an excellent recent review. We report herein a case of psoriasis exacerbated by gemfibrozil, a hypolipidemic fibric acid derivative, in the same category as clofibrate. Gemfibrozil decreases production of very-low-density lipoprotein (VLDL) triglycerides and enhances its clearance, but does not decrease plasma cholesterol.8It does, however, increase high-density lipoprotein (HDL) cholesterol levels.8,9Its mechanism of action, as discussed below, is unclear.8There are no previous reports of psoriasis exacerbated by gemfibrozil (Lopid, Parke-Davis). Moreover, a recent computer search by the American Academy of Dermatology Adverse Drug Reporting Center (Evanston, Ill) failed to reveal any prior reports of this phenomenon. Report of